Rachel Nugent

Biographic Data

ID6455212
NAMERachel Nugent
GIVEN NAMESRachel
FAMILY NAMENugent
SIGNATURENUGENT R
AFFILIATIONSRTI International
ORCID0000-0001-6421-9077
VERIFIEDYes
TOTAL WORKS34
TOTAL CITATIONS32
WORKS AS AUTHOR34
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1996
LATEST PUBLICATION YEAR2025
H-INDEX2

  • The economic impacts of Covid-19 hospitalizations, intensive care unit admissions, and deaths related to overweight and obesity

    Open AccessAdeyemi Okunogbe, Donal Bisanzio et al.ARTICLEPLOS Global Public Health2025

    During the COVID-19 pandemic, it quickly became clear that people living with overweight and obesity (OAO) have a higher risk for more severe health outcomes. The objective of this study is to investigate how the health and economic impacts of COVID-19 are exacerbated by OAO. We estimated economic impacts of COVID-19 associated with OAO for eight countries using a cost-of-illness approach from a limited societal perspective. Direct medical costs …

  • Assessing ‘connective tissue’ in public-private partnerships

    Open AccessGavin Allman, Sumithra Krishnamurthy Reddiar et al.ARTICLEGlobalization and Health2025

    BACKGROUND: Public-private partnerships have the potential to advance solutions to complex dilemmas such as the prevention and control of noncommunicable diseases. Knowledge creation, trust, and social capital among partners - encapsulated in the term "connective tissue" - are key considerations for the cohesion and sustainability of multisectoral collaborative efforts in global health. METHODS: A survey was conducted with 23 stakeholders of proj…

  • Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries

    Open AccessChaoyang Li, Garrison Spencer et al.ARTICLEPLOS Global Public Health2024

    Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for hyperlipidemia in LMICs. A multimethod analysis and multiple data sources were used to assess the accessibility and barriers of medicines for hyperlip…

  • Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban Uganda

    Open AccessDrew Cameron, Lillian Morrell et al.ARTICLEPLOS Global Public Health2024

    Background Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbi…

  • Tackling syndemics by integrating infectious and noncommunicable diseases in health systems of low- and middle-income countries

    Open AccessAngela Jackson‐Morris, Angela Mary Jackson-Morris et al.ARTICLEPLOS Global Public Health2024

    The co-occurrence of infectious diseases (ID) and non-communicable diseases (NCD) is widespread, presenting health service delivery challenges especially in low-and middle-income countries (LMICs). Integrated health care is a possible solution but may require a paradigm shift to be successfully implemented. This literature review identifies integrated care examples among selected ID and NCD dyads. We searched PubMed, PsycINFO, Cochrane Library, C…

  • Advancing progress on tobacco control in low-income and middle-income countries through economic analysis

    Open AccessRoy Small, Rachel Nugent et al.ARTICLETobacco Control2024

    Tobacco control must be seen as more than a health concern. Tobacco control leads to economic benefits and contributes to sustainable development. National investment cases can support country ownership and leadership to advance tobacco control

  • Equity implications of tobacco taxation

    Open AccessGarrison Spencer, Rachel Nugent et al.ARTICLETobacco Control2024

    Our results confirm that health benefits from increases in price through taxation are pro-poor. Even in countries where smoking prevalence is higher among wealthier groups, increasing prices can still be pro-poor due to variable responsiveness to higher prices. The costs associated with higher smoking prevalence among the poor, together with often limited access to healthcare services and displaced spending on basic needs, result in health inequa…

  • Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries

    Open AccessNathan Mann, Garrison Spencer et al.ARTICLETobacco Control2024

    WHO FCTC tobacco control measures would provide a positive return on investment in every country analysed

  • Evolving methodology of national tobacco control investment cases

    Open AccessRachel Nugent, Brian Hutchinson et al.ARTICLETobacco Control2024

    Investment cases constitute a tool that development partners and advocates have demanded in even greater numbers. The economic argument for tobacco control provided by this set of country-contextualised analyses can be a strong tool for policy change

  • The role of Primary Health Care, primary care and hospitals in advancing Universal Health Coverage

    Open AccessLuke N Allen, Luisa M Pettigrew et al.ARTICLEBMJ Global Health2023

  • Strengthening evidence to inform health systems

    Open AccessAdnan A Hyder, Sarah Rylance et al.ARTICLEBMJ Global Health2023

  • Identifying the necessary capacities for the adaptation of a diabetes phenotyping algorithm in countries of differing economic development status

    Open AccessAngela Jackson‐Morris, Angela Mary Jackson-Morris et al.ARTICLEGlobal Health Action2023

    BACKGROUND: In 2019, the World Health Organization recognised diabetes as a clinically and pathophysiologically heterogeneous set of related diseases. Little is currently known about the diabetes phenotypes in the population of low- and middle-income countries (LMICs), yet identifying their different risks and aetiology has great potential to guide the development of more effective, tailored prevention and treatment. OBJECTIVES: This study review…

  • Community priorities for obesity prevention among low-income adults in Kuala Lumpur

    Open AccessErica L Kocher, Dallas Wood et al.ARTICLEHealth Promotion International2022

    Non-communicable diseases and associated risk factors, such as obesity, are prevalent and increasing in Malaysia. To address this burden and the heightened vulnerability of low-income communities to these risk factors, the Better Health Programme Malaysia conducted a partial-profile discrete choice experiment (DCE) to inform the design of a community-based obesity-prevention programme. The DCE survey was conducted with community members (n = 1453…

  • The global return on investment from preventing and treating adolescent mental disorders and suicide

    Open AccessRachel D Stelmach, Erica L Kocher et al.ARTICLEBMJ Global Health2022

    INTRODUCTION: Despite the high burden of mental disorders among adolescents and the potentially lifelong consequences of these conditions, access to mental health services remains insufficient for adolescents in low-income and middle-income countries. We conducted an economic modelling study to quantify the potential costs and benefits of mental health interventions to prevent or treat anxiety, depression, bipolar disorder, and suicide among adol…

  • ‘Implementability’ matters

    Open AccessAngela Jackson‐Morris, Angela Mary Jackson-Morris et al.ARTICLEBMJ Global Health2022

    The ‘implementation gap’ between national plans and successful implementation is a central theme in addressing non-communicable diseases (NCDs). It is a factor that has undermined Sustainable Development Goal 3.4, which aims to achieve a one-third reduction in premature mortality from four major NCDs by 2030. Responding to the potential of implementation research to support low-income and middle-income countries to effectively advance their strat…

  • Models of lifelong care for children and adolescents with chronic conditions in low-income and middle-income countries

    Open AccessLindsey K Reif, J Van Olmen et al.ARTICLEBMJ Global Health2022

    Globally, non-communicable diseases (NCDs) or chronic conditions account for one-third of disability-adjusted life-years among children and adolescents under the age of 20. Health systems must adapt to respond to the growing burden of NCDs among children and adolescents who are more likely to be marginalised from healthcare access and are at higher risk for poor outcomes. We undertook a review of recent literature on existing models of chronic li…

  • Economic impacts of overweight and obesity

    Open AccessAdeyemi Okunogbe, Rachel Nugent et al.ARTICLEBMJ Global Health2022

    INTRODUCTION: The scope of the challenge of overweight and obesity (OAO) has not been fully realised globally, in part because much of what is known about the economic impacts of OAO come from high-income countries (HICs) and are not readily comparable due to methodological differences. Our objective is to estimate the current and future national economic impacts of OAO globally. METHODS: We estimated economic impacts of OAO for 161 countries usi…

  • The case for investment in tobacco control

    Open AccessBrian Hutchinson, Farisha Brispat et al.ARTICLERevista Panamericana de Salud…2022

    Objective. To synthesize learnings from four national tobacco control investment cases conducted in the Americas (Colombia, Costa Rica, El Salvador, Suriname) under the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) 2030 project, to describe results and how national health authorities have used the cases, and to discuss implications for the role of investment cases in advancing tobacco control. Methods. We draw on fi…

  • Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries

    Open AccessAndrew E Moran, Margaret Farrell et al.ARTICLERevista Panamericana de Salud…2022

    Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-investment for the individual country context. The World Health Organization (WHO) and the Pan American Health Organization (PAHO) established a stand…

  • Economic impacts of overweight and obesity

    Open AccessAdeyemi Okunogbe, Rachel Nugent et al.ARTICLEBMJ Global Health2021

    BACKGROUND: Obesity is a growing public health challenge worldwide with significant health and economic impacts. However, much of what is known about the economic impacts of obesity comes from high-income countries and studies are not readily comparable due to methodological differences. Our objective is to demonstrate a method for estimating current and future national economic impacts of obesity and apply it across a sample of heterogeneous con…

  • The Lancet NCDI Poverty Commission

    Open AccessGene Bukhman, Ana Olga Mocumbi et al.ARTICLEThe Lancet2020

  • Tailored support for national NCD policy and programme implementation

    Open AccessAngela Jackson‐Morris, Angela Mary Jackson-Morris et al.ARTICLEBMJ Global Health2020

    Many low-income and middle-income countries (LMICs) are unlikely to achieve Sustainable Development Goal 3.4 to reduce premature deaths from non-communicable diseases (NCDs) by one-third by 2030. For some, the prospect is receding: between 2010 and 2020, the decline in premature deaths for the major NCDs slowed compared with the prior decade. Barriers to implementing effective strategies are well known, yet the value of tailored technical support…

  • The cost-effectiveness of hypertension management in low-income and middle-income countries

    Open AccessDobrinka Kostova, Garrison Spencer et al.ARTICLEBMJ Global Health2020

    Hypertension in low-income and middle-income countries (LMICs) is largely undiagnosed and uncontrolled, representing an untapped opportunity for public health improvement. Implementation of hypertension control strategies in low-resource settings depends in large part on cost considerations. However, evidence on the cost-effectiveness of hypertension interventions in LMICs is varied across geographical, clinical and evaluation contexts. We conduc…

  • Strengthening resistance to the Covid-19 pandemic and fostering future resilience requires concerted action on obesity

    Open AccessAngela Jackson‐Morris, Angela Mary Jackson-Morris et al.ARTICLEGlobal Health Action2020

    Initial observations showed that people with chronic noncommunicable diseases were at heightened risk of severe COVID-19 and adverse outcomes. Subsequently, data from various countries have revealed obesity as an independent and significant factor, with people who are overweight/have obesity significantly more likely to be hospitalized, require ICU treatment, and to die. Notably, this additional risk applies to younger people relative to the gene…

  • Noncommunicable disease outcomes and the effects of vertical and horizontal health aid

    Open AccessDobrinka Kostova, Deliana Kostova et al.ARTICLEEconomics & Human Biology2020

    Foreign health aid forms a substantial portion of health spending in many low- and middle-income countries (LMICs). It can be either vertical (funds earmarked for specific diseases) or horizontal (funds used for broad health sector strengthening). Historically, most health aid has been disbursed vertically toward key infectious diseases, with minimal allocations to noncommunicable diseases (NCDs). High NCD burden in LMICs underscores a need for i…